1. Home
  2. CTW vs ZTEK Comparison

CTW vs ZTEK Comparison

Compare CTW & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$1.46

Market Cap

93.6M

Sector

Technology

ML Signal

N/A

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

HOLD

Current Price

$0.67

Market Cap

78.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTW
ZTEK
Founded
2013
2008
Country
Employees
N/A
N/A
Industry
EDP Services
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
93.6M
78.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTW
ZTEK
Price
$1.46
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.9K
70.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.60
52 Week High
$4.88
$1.84

Technical Indicators

Market Signals
Indicator
CTW
ZTEK
Relative Strength Index (RSI) 41.89 38.88
Support Level $1.10 $0.62
Resistance Level $1.99 $0.69
Average True Range (ATR) 0.21 0.07
MACD 0.02 -0.01
Stochastic Oscillator 34.19 17.10

Price Performance

Historical Comparison
CTW
ZTEK

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: